Roche

Should Merck, BMS Fear Roche's Drug Becoming The I-O King?
Seeking Alpha
Fri, 02/24/17 - 09:10 am
Merck
Bristol-Myers Squibb
Roche
immuno-oncology
Tecentriq
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
FDA
Novartis
Zykadia
ALK-positive non-small cell lung cancer
non-small cell lung cancer
Roche
Alecensa
Roche says Phase II trial supports twin treatment for kidney cancer
Yahoo/Reuters
Sat, 02/18/17 - 02:35 pm
Roche
kidney cancer
Tecentriq
Roche gears up to enter loaded hemophilia A drug market
Medical Marketing and Media
Thu, 02/16/17 - 03:11 pm
Roche
hemophilia A
emicizumab
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
2 Big Reasons Exelixis, Inc. Soared 22% in January
Motley Fool
Thu, 02/2/17 - 09:17 am
Exelixis
Cotellic
Roche
cabozantinib
Takeda
Roche: What To Expect At FY 2016 Results
Seeking Alpha
Mon, 01/30/17 - 11:46 am
Roche
earnings
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:39 pm
Merck
Sanofi
Eli Lilly
Pfizer
Roche
AstraZeneca
Gilead Sciences
Allergan
GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Bristol-Myers Squibb
Merck
Roche
Gilead Sciences
Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Roche
Bristol-Myers Squibb
Tecentriq
non-small cell lung cancer
Opdivo
Did Roche Just Hand Illumina Pacific Biosciences’ Head on a Platter?
Motley Fool
Thu, 01/19/17 - 11:34 pm
Roche
Illumina
Pacific Biosciences
diagnostics
Roche’s Multiple Sclerosis Drug Shows Positive Results in Several Clinical Trials
Xtalks
Fri, 01/13/17 - 11:20 am
Roche
MS
multiple sclerosis
ocrelizumab
clinical trials
Roche Has Aphinity For Perjeta Trial Success, But Not Puma
Seeking Alpha
Sun, 01/8/17 - 03:28 pm
Roche
Perjeta
Puma Biotechnology
breast cancer
Roche touts efficacy of MS drug despite delays
BioPharma Dive
Tue, 12/27/16 - 10:16 am
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche Finds Safe Haven In Emicizumab
Seeking Alpha
Sat, 12/24/16 - 12:13 pm
Roche
emicizumab
hemophilia A
Roche readies a hunt for marketing OK on hemophilia blockbuster hopeful emicizumab after PhIII success
Endpoints
Thu, 12/22/16 - 11:40 am
Roche
hemophilia A
ACE910
emicizumab
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Ophthalmic Drugs Market
Ocular Therapeutix
Eylea
Restasis
Lucentis
Regeneron
Roche
Allergan
FDA pushes decision on Roche MS drug to March
BioPharma Dive
Wed, 12/21/16 - 11:13 am
FDA
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche's Leukemia Drug Approved for Next Step in Europe
Yahoo/GuruFocus
Mon, 12/12/16 - 09:30 am
Roche
chronic lymphocytic leukemia
Europe
venetoclax
Venclyxto
Alnylam touts hemophilia drug's edge over Roche rival
BioPharma Dive
Fri, 12/2/16 - 10:48 am
Alnylam
Roche
hemophilia
fitusiran

Pages